Advanced search

Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.

Currently, Camille Bonnel is Head-Research at Tritax Big Box REIT Plc. In the past Ms. Bonnel was Research Analyst at Merrill Lynch International and Analyst at RBC Europe Ltd. (Broker).

Ms. Camille Burckhart is a Chief Information & Digital Officer, Executive VP at Popular, Inc. She is on the Board of Directors at Fundación Banco Popular, Inc. and Nuestra Escuela, Inc.

Camille Jojo is currently working as the Executive Director & Head-Legal & Compliance at Techtronic Industries Co., Ltd.
Prior to this, Mr. Jojo worked as a Member at the Chartered Institute of Arbitrators (East Asia Branch) and as a Partner at Norton Rose Fulbright (Services) Ltd.
Mr. Jojo graduated from the University of Cardiff in 1977.

Founder of Companhia Brasileira de Tecnologia para E-Commerce and VTEX (Cayman Islands), Mariano Gomide de Faria currently is Chairman & Co-Chief Executive Officer at Companhia Brasileira de Tecnologia para E-Commerce and Co-Chairman & Co-Chief Executive Officer at VTEX (Cayman Islands). He is also on the board of VTEX Ecommerce Platform Ltd.

Boss of the holding company Carlo Tassara International, Romain Zaleski is the eighth richest man in France according to the professional magazine Challenges. Arcelor shareholders with 7.8%, he holds 13% of French metals group Eramet, 2% stake in the insurer Generali and 3% stake in Vinci alongside another Baron, Francois Pinault.

Son of an intellectual Polish and a mother doctor, Romain Zaleski grew up in a famous family of the Polish aristocracy. In 1943, his father, who had joined the resistance is arrested in France before being deported to Buschenwald. A year later, it was his mother who was deported to Ravensbruck.

In 1951, Romain Zaleski accessit gets a diploma in math and physics, which opened the doors of Polytechnic in 1953. In 1958, he graduated from the famous Ecole Nationale Supérieure des Mines de Paris before joining the civil service. He worked in various ministries including the Ministry of Industry before leaving in 1972 for Revillon, a financial company where he worked for seven years.

During his consulting projects he did for Camilog, he visits the factory of steel Carlo Tassara that has cash flow problems.
Convinced that intelligent management would avoid the bankruptcy, he took the helm and he avoids bankruptcy. This successful experience encouraged him to invest in multiple companies specializing in steel and energy. In recent years, he is considered as a specialist of business rescue in peril.

In Italy, he has invested in many banks. He is a notable, especially since the day where he allowed EDF to get Montedison.
In 2005, His rigor and discretion allow him to be an intermediate in the transaction that allows the merger of Arcelor and Mittal.

In 2009, Romain Zaleski has seen his fortune reduced by over 60% becoming the fourth richest man in France.

Currently, Gérard Rene Camille Deman occupies the position of Chairman & Chief Executive Officer for Drakkar Holdings SA and Chairman for Adisseo France SAS. He is also on the board of China National BlueStar (Group) Co., Ltd., Bluestar Adisseo Co. (former Chairman) and Bluestar Adisseo Nutrition Group Ltd. Mr. Deman previously occupied the position of Director-Manufacturing, Purchasing & Supply Chain at Aventis Animal Nutrition, Inc. and Vice President-Corporate Manufacturing at Solvay France SA.

Jorge Alberto de Faria Reis is the founder of Ingresso.com Ltda.
founded in 1999.
He is also the founder of Intellitix Brasil Tecnologia Ltda., Tudus Comercio E Servicos Ltda.
Currently, he holds the position of Independent Director at Ubook Editora SA. Previously, he worked as Co-Chief Operating Officer at Americanas SA. He completed his undergraduate degree in 1990 and his MBA in 1997 from Pontifícia Universidade Católica do Rio de Janeiro.
In 2007, he completed his graduate degree from Federal University of Rio de Janeiro.

Camille Loyo Faria currently works at Timor Telecom SA, as Chairman, Cia Santomense de Telecomunicacoes SARL, as Director, Petrorecôncavo SA, as Independent Director, and Americanas SA, as Chief Financial & Investor Relations Officer from 2023.
Ms. Loyo Faria also formerly worked at Bank of America Merrill Lynch Banco Multiplo SA, as Managing Director, Banco Bradesco de Investimentos SA, as Managing Director, Oi SA, as Chief Financial & Investors Relations Officer from 2019 to 2021, Terna Participaçoes SA, as Chief Financial Officer, Multiner SA, as Chief Executive & Investor Relations Officer, and TIM SA (Brazil), as Chief Financial Officer from 2021 to 2023.
Ms. Loyo Faria received her undergraduate degree and graduate degree from Pontifícia Universidade Católica do Rio de Janeiro and Masters Business Admin degree from Ibmec Rio De Janeiro.

Anthony Faria worked as a Creative Director at Oath, Inc. and Function(x), Inc. from 2011 to 2016.
He obtained an undergraduate degree from the University of the Arts.

Rodrigo Faria is currently working as an Equity Research Analyst at Sul América Investimentos Gestora de Recursos SA since 2020.
Prior to this, he worked as an Investor Relations Manager at CSU Digital SA.

Joao Faria is an Independent Director at NN, Inc. since 2021.
He previously served as the President-Vehicle Group at Eaton Corp.
starting in 1987.
Before that, he held positions as the President-Americas Region at Eaton Hydraulics, Inc. and as the President-Regional at Hydraulics Group.
Mr. Faria has a graduate degree and an MBA from the University of Sao Paulo, and an undergraduate degree from Universidade Federal de São Carlos.

Mr. Gabriel Faria is a Director at Guardian Media Ltd.
He is on the Board of Directors at Guardian Media Ltd.

Anne Marie Faria is currently the Chief Marketing Officer, Chief Sales Officer & EVP at HealthPlan Holdings, Inc. and HealthPlan Services, Inc. She previously worked as a Principal at New England Financial from 1974 to 2000.

Pedro de Andrade Faria has current job as a Director at PetLove Cayman Ltd.

Duarte Faria currently works as a Director at the Associação Portuguesa de Gestão e Engenharia Industrial.

Julio J.
Faria was associated with Surface Transforms Plc as a Non-Executive Director.
He is also the founder of Surface Transforms Plc, which was founded in 1992.

Walter Faria has worked as Deputy Director-Operations at Federação Brasileira de Bancos since 2010.

Denise Faria has a current job as Co-Secretary at Neoenergia SA.

Mario Faria worked as the Chief Data Officer at Concentrix SREV, Inc.

Cristian Faria is an Equity Research Analyst who currently works at Itaú Corretora de Valores SA since 2021.
Prior to this, he worked as an Equity Research Analyst at Fundação Petrobras de Seguridade Social Petros from 2016 to 2020 and at Bradesco SA CTVM from 2020 to 2021.

Kirsten Faria worked as SVP-Bermuda & International Healthcare at Allied World Assurance Company Holdings AG.

Luis A.
Faria currently works at Rensource, Inc., as Director and Rensource Holdings, Inc., as Director.

Ms. Rahman joined OpenView Labs in July, 2010, after having worked with Copernicus, a marketing strategy consulting firm, for two years.
Ms. Rahman graduated from Middlebury College with a B.A.
in Economics.
While at Middlebury, she was the Co-Chair of the Symposium Committee and a House Manager at the Center for the Arts.
During her junior year, she studied abroad at the University of Nottingham in England.

Maria Faria is currently working as a Manager-Accounting at FAX Capital Corp.
since 2020.
Prior to this, she worked as an Accounting Director at Sentry Investments, Inc.

Gustavo Faria currently works at Merrill Lynch SA CVTM, as Research Analyst from 2020.

Emerson Faria worked as the Head of Investor Relations at Porto Seguro SA from 2019 to 2022.
Prior to that, he held the same position at Banco ABC Brasil SA.

Artur Faria worked as the Director-M&A, Business Development at Braskem SA from 2013 to 2022.

Melissa Faria currently works at Jones Lang LaSalle, Inc., as Specialty Leasing Manager from 2018.

Camille F.
Sarrouf is currently the Director at St. Jude Children's Research Hospital, Inc. He previously served as the Chairman at American Lebanese Syrian Associated Charities, Inc.

Camille I.
Farhat currently works at Safeguard Medical LLC, as Executive Chairman from 2022, Advanced Medical Technology Association, as Director, Northwestern Memorial Hospital, as Advisory Council Member, and Water Street Healthcare Partners LLC, as Executive Advisor from 2021.
Mr. Farhat also formerly worked at Surgalign Spine Technologies, Inc., as President, Chief Executive Officer & Director, American Medical Systems, Inc., as President & CEO from 2012 to 2015, Surgalign Holdings, Inc., as President, Chief Executive Officer & Director from 2017 to 2020, RTI Surgical, Inc. (Florida), as President & Chief Executive Officer from 2017 to 2020, Cardiac Science Corp., as Director from 2016 to 2019, CMR Surgical Ltd., as Director from 2018 to 2021, Lau Health Foundation, Inc., as Director from 2011 to 2016, Baxter International, Inc., as Global GM-Baxter Pharmaceuticals & Technologies from 2008 to 2011, General Electric Financial Services, Inc., as Principal from 1993 to 2001, Medtronic, Inc., as Vice President-Business Development from 2003 to 2006, Astora Women's Health, Inc., as President, NXThera, Inc., as Board Member from 2012 to 2015, GE Healthcare (Ventures), as Principal from 2001 to 2003, and Global Infusion Systems, as Principal.
Mr. Farhat received his Masters Business Admin degree in 1998 from Harvard University, undergraduate degree in 1991 from Northeastern University, and undergraduate degree from Sciences Po.

Camille R.
Bash is currently the Chief Financial Officer & Treasurer at Doctors Hospital, Inc. and a Fellow at Healthcare Financial Management Association.
Previously, she worked as the Chief Financial Officer at Washington Homes, Inc., Vice President-Business Operations at Children's National Hospital (District of Columbia), Administrator at Medlink Hospital & Nursing Center, and Chief Financial Officer at Catholic Charities.
Dr. Bash holds an MBA from the University of Missouri, an undergraduate degree from The University of Texas at Austin, and a graduate degree from Webster University.

Camille Olivere worked as a Principal at American Express Co., Oracle Corp., United Air Lines, Inc., and Signature Group.
She was also a Vice President-Sales at Travelport Americas, Inc. Olivere served as Senior Vice President-Sales at NCL Corp.
Ltd.
from 2009 to 2014 and at Norwegian Cruise Line Holdings Ltd.
from 2016 to 2020.
She was also Senior Vice President-Partner Brands at World Travel Holdings, Inc. from 2015 to 2016.
Olivere earned an undergraduate degree from the University of Michigan.